TetraLogic Pharmaceuticals Corporation
TLOG · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $40,988 | $107,438 | $21,854 | $6,790 |
| - Cash | $15,302 | $13,073 | $55,136 | $4,512 |
| + Debt | $28,279 | $28,979 | $0 | $4,756 |
| Enterprise Value | $53,964 | $123,344 | -$33,281 | $7,034 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$188 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$43,152 | -$32,474 | -$17,083 | -$15,972 |
| % Margin | – | – | – | – |
| Net Income | -$56,108 | -$39,318 | -$22,718 | -$16,273 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.36 | -1.76 | -9.9 | -16.78 |
| % Growth | -34.1% | 82.2% | 41% | – |
| Operating Cash Flow | -$34,889 | -$32,366 | -$12,769 | -$15,928 |
| Capital Expenditures | -$77 | -$515 | -$67 | -$29 |
| Free Cash Flow | -$34,967 | -$32,881 | -$12,836 | -$15,956 |